Scott R Sommers

Learn More
Nine plasma cell myeloma patients spontaneously developed histologically proven autologous graft-versus-host disease (GVHD) limited predominantly to the gastrointestinal tract within 1 month of initial autologous hematopoietic cell transplantation (AHCT) using high-dose melphalan conditioning. All recipients responded promptly to systemic and nonabsorbable(More)
Plasma cell myeloma, characterized by clonally aberrant plasma cells that produce abnormal monoclonal Igs, is the most common indication for autologous hematopoietic progenitor cell transplantation (AHPCT) in North America. We observed appearance of new monoclonal gammopathies different from the original protein in the post-AHPCT setting and termed this(More)
e14661 Background: Vascular endothelial growth factor (VEGF) is over expressed in 30-60% of pts with esophageal cancer, with high levels associated with poor prognosis. Sunitinib is a tyrosine kinase inhibitor targeting VEGF receptors (types 1-3). Taxanes have single-agent activity in esophageal cancer including anti-angiogenic properties. We studied the(More)
  • 1